Abstract:The development of highly efficient and minimally toxic agents with targeting abilities toward tumor tissues is an ongoing area of research in the fight against cancer. Different from the mononuclear and multinuclear metallodrug complexes, impressively, the unique supramolecular coordination complexes (SCCs) have shown great superiority in cancer treatment. The vast combinational flexibility of ligands and metal ions offers limitless opportunities to form desired SCCs, thus endows them with distinct, captivating and integrated biological and chemical properties. Compared to organic drugs that are predominantly one-dimensional (1D) or two-dimensional (2D) in shape, the structurally much more complicated three-dimensional (3D) multinuclear assemblies with elaborate sizes, shapes, or cavities can exhibit unexpected binding sensitivity and selectivity toward biomolecules. Over the last decades, significant progress has been made in the design and synthesis of novel SCCs for intensive cancer therapy. These assemblies have been formulated using new strategies and formulations, resulting in nonclassical action modes that show promising results. This review aims at gathering innovative multinuclear Pt(II), Ru(II), and Ir(III)-based metallo-assemblies as promising anticancer drugs. Each section is divided into different parts based on the number of metal ions and shapes of the assembly. Furthermore, the review concludes with an exploration of the regulatory factors of structure design and discusses the perspectives for the practical impact of this type of research in medicinal chemistry. It is expected that this review will afford important guidance for the further development of these promising anticancer agents in biological applications, resulting in innovative anticancer agents that continue along this already promising path.

Assembling a new generation of radiopharmaceuticals with supramolecular theranostics

Coordination-assembled Supramolecular Nanoplatforms: Structural Modulation and Theranostic Applications

Host-Guest Chemistry in Supramolecular Theranostics

Biomedical applications of multinuclear Pt(II)/Ru(II)/Ir(III) metallo-supramolecular assemblies for intensive cancer therapy

Cancer‐Selective Supramolecular Chemotherapy by Disassembly‐Assembly Approach

Supramolecular Coordination Complexes As Diagnostic and Therapeutic Agents

Metal Ion-Based Supramolecular Self-Assembly for Cancer Theranostics

Metal‐Coordinated Supramolecular Self‐Assemblies for Cancer Theranostics

Multimodal Therapeutic Platforms Based on Self‐Assembled Metallacycles/Metallacages for Cancer Radiochemotherapy

Supramolecular Cancer Nanotheranostics

An Overview of Structural Framework and Classification of Theranostic Radiopharmaceuticals

Designing Supramolecular Self-Assembly Nanomaterials As Stimuli-Responsive Drug Delivery Platforms for Cancer Therapy.

Phosphorescent Metal Complexes As Theranostic Anticancer Agents: Combining Imaging and Therapy in a Single Molecule.

Supramolecular approaches to biological therapy.

Design and Application of Nuclear and Molecular Theragnostic Probes

Nanomaterials with Supramolecular Assembly Based on AIE Luminogens for Theranostic Applications

Supramolecular metal-based nanoparticles for drug delivery and cancer therapy

Covalently triggered self-assembly of peptide-based nanodrugs for cancer theranostics

Supramolecular Nanomedicines of <i>In-Situ</i> Self-Assembling Peptides

Multiple hydrogen bonding driven supramolecular architectures and their biomedical applications

Supramolecular peptide nano-assemblies for cancer diagnosis and therapy: from molecular design to material synthesis and function-specific applications